Navigation Links
Gq-coupled receptor assays using FLEXstation: M1 muscarinic receptor



FLEXSTATION IS A VERSATILE TOOL FOR ASSAY DEVELOPMENT AND BASIC RESEARCH

SIMPLE, RAPID EXPERIMENTAL SET-UP AND DATA ANALYSIS

DETERMINE EC50 AND IC50 VALUES

EXCELLENT FOR ASSAY DEVELOP-MENT AS DEMONSTRATED BY Z FACTOR


INTRODUCTION

Gq-coupled receptors are transmembrane proteins that are responsible for transmitting extracellular signals to the inside of the cell, which ultimately leads to changes in gene expression. Some Gq-coupled receptors can be activated through the specific binding of ligands or drugs to the extracellular domains of the protein. This interaction leads to downstream events such as mobilization of calcium from intracellular storage vesicles into the cytoplasm of the cell. Improper Gq-coupled receptor function is implicated in cancer, neurodegenerative and cardiovascular diseases. Therefore, it is important to compare receptor function in normal and disease states.

The cell line used in these studies, M1 CHO, is stably transfected with the M1 muscarinic Gqcoupled receptor1. This receptor is stimulated with carbachol, which leads to the release of calcium from the endoplasmic reticulum into the cytosol. Activation of the M1 Gq-coupled receptor can be monitored using FLEXstation in conjunction with either the calcium-sensitive fluorescent dye, Fluo-3, or the FLEXstation Calcium Assay Kit from Molecular Devices. The results demonstrate that a similar range of EC50 values is obtained for carbachol using both detection methods.


METHODS
Cells were seeded the night before the experiment at a concentration of 30,000 cells/well in a volume of 100 L per well of black walled, clear bottomed, 96-well microplates (E&K distributors, cat# 655090). Cells were incubated either for one hour with a buffer containing 4.2 M Fluo-3 or for one-half hour with 1X Loading Buffer from the FLEXstation Calcium Assay Kit (Molecular Devices, cat#R8041) before using FLEXstation to dispense carbachol and monitor the mobilization of calcium into the cell cytosol. All experiments were performed at a final concentration of 2.5 mM probenecid in order to inhibit endogenous efflux pumps present in M1 CHO cells.


DETERMINATION OF EC50 VALUES
Cells were exposed to a range of carbachol (0 to 1 M) using half log dilutions of the agonist. Results are representative of at least four independent experiments performed over a period of at least two different days. The raw data was analyzed as Max-Min and Absolute RFU values (Figures 1, 2). The average value of replicate samples was plotted on a graph using a curve fit of four parameter, for which the C value is the concentration of drug that causes 50% of maximal response (EC50 value, see Figure 3). The EC50 values for carbachol using Fluo-3 ranged from 1939 nM, whereas it ranged from 1230 nM using the FLEXstation Calcium Assay Kit (see Figures 3 and 4).



DETERMINATION OF Z FACTOR
Cells in half of the microplate were treated with 0.5 M carbachol, while cells in the other half of the plate were treated with 1X Reagent Buffer (1X HBSS/20 mM HEPES pH 7.4). The FLEXstation Calcium Assay Kit was used to monitor carbachol-mediated calcium mobilization (Figure 5). Z factor was calculated using the formula2:

The terms sc- and sc+ denote the standard deviation of the negative control and positive control, respectively, whereas |c+ c-| denotes the absolute value of the difference in the mean of the positive control and the mean of the negative control. The Z factor obtained for FLEXstation using the FLEXstation Calcium Assay Kit was 0.65. This indicates a large separation band between the negative and positive controls and an optimized, high quality assay.


SUMMARY
FLEXstation generates highly reproducible results for calcium mobilization assays used to monitor the activity of Gq-coupled receptors (Fig. 3). First, the EC50 values obtained for carbachol were consistent between detection methods, Fluo-3 and the FLEXstation Calcium Assay Kit. Also, assays analyzed on the same day showed less than two-fold differences, and assays analyzed on different days showed less than fourfold differences, which further demonstrates the reliable performance of FLEXstation (data not shown). Lastly, the Z factor determination indicates that FLEXstation provides an excellent tool for assay development for the model system examined. In addition, other benefits include SOFTmax PRO software that makes it simple to set up the instrument and analyze the data. Moreover, the dual monochromators provide increased flexibility for assay development or basic research purposes. In conclusion, FLEXstation provides an easy-to-use, versatile tool to help basic research and assay development laboratories reach their goals.

For more detailed information, please refer to the application note Comparison of FLIPR and FLEXstation for Calcium Mobilization Assays, available for download from Molecular Devices web site at:
www.moleculardevices.com/pages/flex_lit1.html


REFERENCES
1. Buck, M. A., and C. M. Fraser. 1990. Biochem. Biophys. Res. Commun. 173: 666672.
2. Zhang, J-H., T.D.Y. Thomas, and K. R. Oldenburg. 1999. J. Biomol. Screening 4: 6773.

SALES OFFICES
USA 800-635-5577
UK +44-118-944-8000
Germany +49-89-9620-2340
Japan +81-6-6399-8211

Check our web site for a current listing of our worldwide distributors.
www.moleculardevices.com


FLEXstation is a trademark of Molecular Devices Corporation.


back to top


'"/>

Source:


Page: All 1 2 3 4

Related biology technology :

1. Gq-coupled Receptor Assays Using FLEXstation
2. Gq-coupled receptor assays: a comparison of FLEXstation and FLIPR
3. The development of a CXCR2 chemokine receptorbinding assay using the LEADseeker Multimodality Imaging System
4. The development of a melanocortin MC4 receptor binding assay using the LEADseeker Multimodality Imaging System
5. The development of a melanocortin MC5 receptor binding assay using the LEADseeker Multimodality Imaging System
6. The development of a calcitonin-gene related peptide (CGRP) receptor-binding assay using the LEADseeker Multimodality Imaging System
7. Screening for potential beta 2-adrenergic receptor antagonists using CypHer5E and IN Cell Analyzer 1000
8. The use of CypHer5 for receptor internalization studies in both a range of GPCRs and a non-GPCR
9. The use of CypHer5E and the IN Cell Analyzer 1000 for live-cell receptor internalization studies
10. Screening for β2-adrenergic receptor agonists using the pH-sensitive dye,CypHer5, and the IN Cell Analyzer 3000
11. Development of a histamine H1 receptor binding assay using the LEADseeker Multimodality Imaging System
Post Your Comments:
(Date:9/2/2015)... , Sept. 2, 2015 Aytu BioScience, Inc. ... treatments for urological and related conditions, announced today that ... private placement convertible note financing, raising a total of ... totaling $3.175 million. Josh Disbrow ... this private placement are intended to be used to ...
(Date:9/2/2015)... Virginia , September 2, 2015 ... der Gewinner des Wettbewerbs BeHEARD von 2015 bekanntgeben ... internationalen vom Rare Genomics Institute. Biovista ... von Medikamenten für die Behandlung anderer Krankheiten als ... Steven Laffoon und sein Team bei ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... equipment, to creating professional commercial video content, to analysis of athletic performance. Producing ... events that go by too quickly to process with the naked eye. ...
(Date:9/1/2015)... CHICAGO , Sept. 1, 2015 The ... of Intent (LOI) for its Discovery Research Grant program. ... 2015 at 12:00 noon CDT. Discovery ... projects with the potential to change current diagnostic or ... These grants specifically encourage novel research at its earliest ...
Breaking Biology Technology:Aytu BioScience Completes $5.175 Million Private Placement 2Aytu BioScience Completes $5.175 Million Private Placement 3Biovista sponsert die Forschung von Wylder Nation Foundation zum Thema Mangel an saurer Sphingomyelinase 2Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 2Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 3American Brain Tumor Association Seeks Innovative Concepts For Discovery Research Grants 2
... assessment to be added to the, ... 28 /PRNewswire-FirstCall/ - Resverlogix Corp. ("Resverlogix" or "Company") ... on activities as well as an interim progress ... is conducting a human Phase 1b/2a clinical trial ...
... Sigma-Aldrich (Nasdaq: SIAL ) today announced the global ... provides a novel and powerful approach to RNAi screening in ... http://www.sigma.com/esirna ) incorporates a pool of hundreds of ... designed to eliminate the trial and error approach of identifying ...
... Techne Corporation,s (Nasdaq: TECH ) consolidated net ... to $27.6 million or $.74 per diluted share compared with ... ended March 31, 2008. For the nine months ended ... $79.9 million or $2.10 per diluted share compared with $76.3 ...
Cached Biology Technology:Resverlogix Provides Quarterly Update 2Resverlogix Provides Quarterly Update 3Resverlogix Provides Quarterly Update 4Sigma-Aldrich Introduces MISSION(R) esiRNA for Low Cost, High Specificity Pooled RNAi Screening 2Sigma-Aldrich Introduces MISSION(R) esiRNA for Low Cost, High Specificity Pooled RNAi Screening 3Sigma-Aldrich Introduces MISSION(R) esiRNA for Low Cost, High Specificity Pooled RNAi Screening 4Techne Corporation Releases Unaudited Third Quarter Results for Fiscal Year 2009 2Techne Corporation Releases Unaudited Third Quarter Results for Fiscal Year 2009 3Techne Corporation Releases Unaudited Third Quarter Results for Fiscal Year 2009 4Techne Corporation Releases Unaudited Third Quarter Results for Fiscal Year 2009 5Techne Corporation Releases Unaudited Third Quarter Results for Fiscal Year 2009 6Techne Corporation Releases Unaudited Third Quarter Results for Fiscal Year 2009 7
(Date:8/10/2015)... Germany , August 10, 2015 ... leader in Eye Tracking Technology for more than two ... Tracking Platform for integration into all consumer display formats. ... for seamless integration of eye tracking into consumer tablets, ... augmented reality smart glasses. Omnivision,s leading sensor technology contributes ...
(Date:8/6/2015)... JOSE, Calif. , Aug. 6, 2015 /PRNewswire/ ... leading developer of human interface solutions, today announced ... TouchPad technologies on Windows 10. Microsoft leveraged Synaptics, ... to the operating system. Through ... drivers are fully certified with Microsoft,s Precision TouchPad ...
(Date:8/4/2015)... Aug. 04, 2015 ... has announced the addition of the ... and Service), Sub-Segment (Computer Forensics, Network Forensics, ... Types, Service, Vertical and Region - Global ... offering. By Component (Hardware, Software, ...
Breaking Biology News(10 mins):SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3Synaptics Chosen for Human Interface Co-Development on Windows 10 2Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2
... can induce a group of aggressive immune cells that ... is the result of a study conducted by Dr. ... Haven and the Broad Institute of the Massachusetts Institute ... Ralf Linker (Dept. of Neurology, University Hospital Erlangen), Professor ...
... today concludes that nearly half of Africa,s wild lion populations ... without urgent conservation measures. The plight of many lion populations ... - and fencing humans out - may be their only ... Minnesota,s Professor Craig Packer and co-authored by a large team ...
... University of Massachusetts Amherst including assistant professor Peter Chien ... degradation help to regulate the delicate ballet of cell ... each other in "mutually assured cleanup" to insure that ... dispose of leftover proteins with the aid of proteases ...
Cached Biology News:International study: Excess dietary salt may drive the development of autoimmune diseases 2International study: Excess dietary salt may drive the development of autoimmune diseases 3New report confirms almost half of Africa's lions facing extinction 2New insight into double-protected dance of cell division 2
Kit contains: Bio-Rad Amplification Reagent, 2x Amplification Diluent, Streptavidin-HRP, Blocking Reagent, and Phosphate Buffered Saline....
Mouse polyclonal antibody to PRDM2 - PR domain containing 2, with ZNF domain...
... Anti-phospho-Hck [pTyr 209/ pSer 211 ] affinity ... in Dulbecco's phosphate buffered saline (without Mg 2+ ... 1.0 mg/ml BSA (IgG and protease free) and ... from the region of mouse Hck that contains ...
... Useful as a positive control for ... to chromatin in vivo is a crucial ... extent of crosslinking is probably the most ... subsequent immunoprecipitation step should be taken into ...
Biology Products: